NFX88, a modified oleic acid molecule, is a nonsteroidal anti-inflammatory drug with GPCR-G protein uncoupling activity that alleviates pain of neural origin.
NFX88 reduces hyperalgesia, which is a common condition in neurological disorders and neurodegenerative diseases, with higher efficacy than the current reference drug, pregabalin. It is formulated for convenient oral administration.
A Phase 2a clinical trial for neuropathic pain in patients with spinal cord injury is currently ongoing.
More information